EA200900338A1 - Вакцины против хламидийной инфекции - Google Patents
Вакцины против хламидийной инфекцииInfo
- Publication number
- EA200900338A1 EA200900338A1 EA200900338A EA200900338A EA200900338A1 EA 200900338 A1 EA200900338 A1 EA 200900338A1 EA 200900338 A EA200900338 A EA 200900338A EA 200900338 A EA200900338 A EA 200900338A EA 200900338 A1 EA200900338 A1 EA 200900338A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- chlamyda
- infection
- vaccines against
- proteins
- chlamydia trachomatis
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241000606153 Chlamydia trachomatis Species 0.000 abstract 2
- 229940038705 chlamydia trachomatis Drugs 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000001860 Eye Infections Diseases 0.000 abstract 1
- 208000011323 eye infectious disease Diseases 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82809206P | 2006-10-04 | 2006-10-04 | |
| PCT/EP2007/060500 WO2008040757A1 (en) | 2006-10-04 | 2007-10-03 | Vaccines against chlamydial infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200900338A1 true EA200900338A1 (ru) | 2009-10-30 |
Family
ID=39092594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200900338A EA200900338A1 (ru) | 2006-10-04 | 2007-10-03 | Вакцины против хламидийной инфекции |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100172927A1 (https=) |
| EP (1) | EP2068916A1 (https=) |
| JP (1) | JP2010505795A (https=) |
| KR (1) | KR20090077065A (https=) |
| CN (1) | CN101522215A (https=) |
| AU (1) | AU2007304199A1 (https=) |
| BR (1) | BRPI0719169A2 (https=) |
| CA (1) | CA2664236A1 (https=) |
| EA (1) | EA200900338A1 (https=) |
| MX (1) | MX2009003127A (https=) |
| WO (1) | WO2008040757A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080213264A1 (en) * | 1998-12-08 | 2008-09-04 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6919187B2 (en) * | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US8541007B2 (en) | 2005-03-31 | 2013-09-24 | Glaxosmithkline Biologicals S.A. | Vaccines against chlamydial infection |
| US9259463B2 (en) * | 2006-01-16 | 2016-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chlamydia vaccine |
| CN103068837B (zh) | 2010-05-28 | 2015-06-24 | 斯匹遐生物技术公司 | 嵌合momp抗原、方法和使用 |
| EP3220962A4 (en) * | 2014-11-21 | 2018-07-25 | Merck Sharp & Dohme Corp. | Recombinant expression of chlamydia momp antigen |
| CN104800841B (zh) * | 2015-03-02 | 2019-04-02 | 中国农业科学院兰州兽医研究所 | 牦牛流产衣原体灭活疫苗及其制备方法 |
| CN111735967B (zh) * | 2020-08-03 | 2020-12-22 | 天津中逸安健生物科技有限公司 | 一种重组新型冠状病毒疫苗吸附完全性检测方法 |
| AR132053A1 (es) | 2023-03-02 | 2025-05-21 | Sanofi Pasteur | Composiciones para su uso en el tratamiento de clamidia |
| WO2025076210A1 (en) * | 2023-10-03 | 2025-04-10 | Vaxcyte, Inc. | Chlamydia vaccine compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100132086A (ko) * | 1998-12-08 | 2010-12-16 | 코릭사 코포레이션 | 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를 포함하는 약제학적 조성물 및 진단 키트 |
| US20020146776A1 (en) * | 2000-04-21 | 2002-10-10 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6919187B2 (en) * | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20030199438A1 (en) * | 2001-04-09 | 2003-10-23 | Shaw Allan Christian | Method for identification of proteins from intracellular bacteria |
| US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
| CN100515494C (zh) * | 2001-12-12 | 2009-07-22 | 启龙有限公司 | 抗沙眼衣原体的免疫 |
| WO2005027961A2 (en) * | 2003-09-23 | 2005-03-31 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Chlamydia pmpd autotransporter and its role as adhesin |
| US7892567B2 (en) * | 2007-10-01 | 2011-02-22 | Board Of Regents, The University Of Texas System | Methods and compositions for immunization against chlamydial infection and disease |
-
2007
- 2007-10-03 MX MX2009003127A patent/MX2009003127A/es not_active Application Discontinuation
- 2007-10-03 CA CA002664236A patent/CA2664236A1/en not_active Abandoned
- 2007-10-03 AU AU2007304199A patent/AU2007304199A1/en not_active Abandoned
- 2007-10-03 EA EA200900338A patent/EA200900338A1/ru unknown
- 2007-10-03 EP EP07820877A patent/EP2068916A1/en not_active Withdrawn
- 2007-10-03 BR BRPI0719169-3A patent/BRPI0719169A2/pt not_active IP Right Cessation
- 2007-10-03 CN CNA2007800373166A patent/CN101522215A/zh active Pending
- 2007-10-03 WO PCT/EP2007/060500 patent/WO2008040757A1/en not_active Ceased
- 2007-10-03 US US12/442,538 patent/US20100172927A1/en not_active Abandoned
- 2007-10-03 JP JP2009530876A patent/JP2010505795A/ja active Pending
- 2007-10-03 KR KR1020097009229A patent/KR20090077065A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009003127A (es) | 2009-06-26 |
| CN101522215A (zh) | 2009-09-02 |
| KR20090077065A (ko) | 2009-07-14 |
| JP2010505795A (ja) | 2010-02-25 |
| CA2664236A1 (en) | 2008-04-10 |
| WO2008040757A1 (en) | 2008-04-10 |
| EP2068916A1 (en) | 2009-06-17 |
| BRPI0719169A2 (pt) | 2014-02-04 |
| US20100172927A1 (en) | 2010-07-08 |
| AU2007304199A1 (en) | 2008-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900338A1 (ru) | Вакцины против хламидийной инфекции | |
| UA97943C2 (ru) | Вакцина против инфекции chlamydia | |
| MX2009003325A (es) | Vacuna que comprende un adyuvante de emulsion de aceite en agua. | |
| MXPA06005639A (es) | Adyuvante antimicrobiano. | |
| NZ595689A (en) | Compositions for immunising against staphylococcus aureus | |
| EA200901078A1 (ru) | Конъюгаты синтетических агонистов tlr и их применение | |
| WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| WO2008071898A3 (fr) | Appareil de traitement par emission de flashs lumineux avec dispositif d'anti-eblouissement | |
| CY1110046T1 (el) | Γαβοξαδολη για τη θεραπεια της καταθλιψης και αλλων συναισθηματικων διαταραχων | |
| EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
| MY152149A (en) | Prevention and treatment of sub-clinical pcvd | |
| BRPI0508451A (pt) | método de tratamento de linfoma não-hodgkin em um mamìfero, usos de uma combinação de cci-779 e rituximab e de uma combinação de um inibidor de mtor e rituximab, produtos contendo cci-779 e rituximab e um inibidor mtor e rituximab, embalagem farmacêutica, e, composição farmacêutica | |
| JP2010505795A5 (https=) | ||
| BRPI0910884A2 (pt) | composição imunogênica, método para tratar ou prevenir infecção ou doença estafilocócicas, e, uso de uma composição imunogênica. | |
| WO2007150008A3 (en) | Polypeptides from african swine virus as vaccines for preventive and therapeutic use | |
| WO2006042149A3 (en) | Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides | |
| BRPI0819839A2 (pt) | Uso de anticorpo humano capaz de neutralizar o vírus da hepatite b para a prevenção ou tratamento da infecção por vírus da hepatite b | |
| WO2008057158A3 (en) | Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications | |
| WO2007082105A3 (en) | Chlamydia vaccine | |
| WO2008153772A3 (en) | Chlamydia vaccine comprising htra polypeptides | |
| BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
| MX2012004133A (es) | Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas. | |
| SG147465A1 (en) | Vaccine | |
| BRPI0410967A (pt) | compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae | |
| WO2008044149A3 (en) | Shigella ipad protein and its use as a vaccine against shigella infection |